Catheter Precision Inc. (NYSE:VTAK) shares jumped 17.39% to $1.08 after the bell on Tuesday, as investors cheered the firm’s partnership with sports and entertainment agency GSE Worldwide and a batch of newly allowed patents covering its heart failure and vascular closure technologies.
Catheter Eyes Elite Athletes
On Monday, Catheter announced its regional air mobility subsidiary Flyte had partnered with GSE Worldwide and PGA Tour pro Emiliano Grillo, with the tie-up launching at the 2026 U.S. Open. Grillo climbed as high as third on the leaderboard before finishing tied for 23rd in one of golf’s most competitive major championships.
Flyte’s Cirrus Vision Jets target short-haul regional routes, a natural fit for athletes juggling packed tournament schedules.
Marc Sellouk, CEO of Flyte, said, “Regional travel is an essential part of an athlete’s lifestyle, and it’s the exact challenge Flyte was built to address.”
